Li, K.; Bosdet, I.; Yip, S.; Ho, C.; Laskin, J.; Melosky, B.; Wang, Y.; Sun, S.
Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer. Curr. Oncol. 2023, 30, 7099-7111.
https://doi.org/10.3390/curroncol30080515
AMA Style
Li K, Bosdet I, Yip S, Ho C, Laskin J, Melosky B, Wang Y, Sun S.
Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer. Current Oncology. 2023; 30(8):7099-7111.
https://doi.org/10.3390/curroncol30080515
Chicago/Turabian Style
Li, Kelly, Ian Bosdet, Stephen Yip, Cheryl Ho, Janessa Laskin, Barbara Melosky, Ying Wang, and Sophie Sun.
2023. "Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer" Current Oncology 30, no. 8: 7099-7111.
https://doi.org/10.3390/curroncol30080515
APA Style
Li, K., Bosdet, I., Yip, S., Ho, C., Laskin, J., Melosky, B., Wang, Y., & Sun, S.
(2023). Real-World Clinical Outcomes for Patients with EGFR and HER2 Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer. Current Oncology, 30(8), 7099-7111.
https://doi.org/10.3390/curroncol30080515